ROMOSOZUMAB AQQG and FALL

Overview

FALL is the #1 most commonly reported adverse reaction for ROMOSOZUMAB AQQG, manufactured by Amgen, Inc. There are 699 FDA adverse event reports linking ROMOSOZUMAB AQQG to FALL. This represents approximately 4.6% of all 15,195 adverse event reports for this drug.

Patients taking ROMOSOZUMAB AQQG who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

FALL is moderately reported among ROMOSOZUMAB AQQG users, representing a notable but not dominant share of adverse events.

Other Side Effects of ROMOSOZUMAB AQQG

In addition to fall, the following adverse reactions have been reported for ROMOSOZUMAB AQQG:

• FRACTURE — 635 reports
• ARTHRALGIA — 561 reports
• INJECTION SITE PAIN — 519 reports
• OFF LABEL USE — 460 reports
• BONE DENSITY ABNORMAL — 456 reports
• HOSPITALISATION — 411 reports
• HEADACHE — 401 reports
• PRODUCT STORAGE ERROR — 352 reports
• PAIN IN EXTREMITY — 277 reports
• SPINAL FRACTURE — 275 reports

Other Drugs Associated with FALL

The following drugs have also been linked to fall in FDA adverse event reports:

Does ROMOSOZUMAB AQQG cause FALL?

FALL has been reported as an adverse event in 699 FDA reports for ROMOSOZUMAB AQQG. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is FALL with ROMOSOZUMAB AQQG?

FALL accounts for approximately 4.6% of all adverse event reports for ROMOSOZUMAB AQQG, making it one of the most commonly reported side effect.

What should I do if I experience FALL while taking ROMOSOZUMAB AQQG?

If you experience fall while taking ROMOSOZUMAB AQQG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages